Latest Period
Q2 2026
Security Snapshot
Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI) Institutional Ownership
CUSIP: 753018100
13F Institutional Holders and Ownership History from Q3 2021 to Q2 2026
Institutions Reporting
66
Shares (Excl. Options)
45,546,868
Price
$0.76
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Common Stock, $0.0001 par value per share
- Symbol
- RANI on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 45,546,868
- Total 13F value
- $34,631,523
- Portfolio coverage rank
- 0%
- Share change
- +6,629,693
- Value change
- +$5,075,458
- Number of holders
- 66
- Shares outstanding
- 116,468,828
- SEC-reported price per share
- $0.70
- Insider filing price
- $0.70
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- RANI - Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share is tracked under CUSIP 753018100.
- 66 institutions reported positions in Q2 2026.
- 10 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 73 to 66 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $31,411,019 to $34,631,523.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 66 institutions filings for Q2 2026.
Security key
753018100
Latest holder period
Q2 2026
13F holders
66
13D/G owners
10
CIK / CUSIP context first
Open Q2 2026 holders
RANI full holder history
Rani Therapeutics Holdings, Inc. SEC filings
Rani Therapeutics Holdings, Inc. company facts
Rani Therapeutics Holdings, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 753018100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
10
Security
RANI
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| InCube Labs, L.L.C. | 22% | $13,541,357 | 27,093,552 | MIR A IMRAN | 23 Oct 2025 | |||
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | 0% | $8,763,115 | +$1,252,432 | 11,530,414 | +17% | RA Capital Management, L.P. | 30 Jun 2026 |
| Samsara BioCapital, L.P. | 9.9% | 0% | $10,417,124 | +$1,325,245 | 11,322,961 | +15% | Srinivas Akkaraju | 26 May 2026 |
| Invus Global Management, LLC | 10% | $4,910,990 | 9,825,911 | Raymond Debbane | 16 Oct 2025 | |||
| AWM Investment Company, Inc. | 9.9% | $14,520,561 | 9,745,343 | AWM Investment Company, Inc. | 31 Dec 2025 | |||
| ARMISTICE CAPITAL, LLC | 9.9% | $4,131,600 | 6,260,000 | Armistice Capital, LLC | 30 Jun 2025 | |||
| VANGUARD GROUP INC | 5.2% | $6,897,647 | 5,109,368 | The Vanguard Group | 31 Dec 2025 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | $3,840,175 | 5,052,862 | Vanguard Capital Management | 30 Jun 2026 | |||
| South Cone Investments Limited Partnership | 4.9% | $1,189,121 | 2,379,194 | South Cone Investments Limited Partnership | 20 Oct 2025 | |||
| Orca Capital AG | 4.3% | -56% | $972,105 | -$1,265,416 | 1,891,623 | -57% | Orca Capital AG | 22 Jul 2025 |
As of 30 Jun 2026, 66 institutional investors reported holding 45,546,868 shares of Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI). This represents 39% of the company’s total 116,468,828 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
39%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | 8.9% | 10,369,159 | +22% | 0.65% | $7,884,709 |
| RA CAPITAL MANAGEMENT, L.P. | 7.3% | 8,500,000 | 0% | 0.06% | $6,463,400 |
| AWM Investment Company, Inc. | 6.4% | 7,500,000 | +15% | 0.49% | $5,703,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.9% | 4,562,985 | -1.3% | 0% | $3,467,869 |
| Longaeva Partners L.P. | 2% | 2,329,459 | 0% | 0.05% | $1,771,321 |
| Polar Asset Management Partners Inc. | 2% | 2,318,542 | 0.03% | $1,763,019 | |
| Siren, L.L.C. | 1.7% | 2,000,000 | 0% | 0.03% | $1,520,800 |
| HEIGHTS CAPITAL MANAGEMENT, INC | 0.8% | 934,580 | 0.16% | $710,655 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.76% | 890,618 | -1.4% | 0% | $677,575 |
| CITADEL ADVISORS LLC | 0.55% | 641,995 | 0% | $488,173 | |
| MARSHALL WACE, LLP | 0.5% | 586,265 | 0% | $445,561 | |
| Nan Fung Group Holdings Ltd | 0.42% | 493,584 | 0% | 0.29% | $375,321 |
| JANE STREET GROUP, LLC | 0.42% | 485,899 | +193% | 0% | $369,478 |
| VANGUARD FIDUCIARY TRUST CO | 0.39% | 458,126 | +0.68% | 0% | $348,176 |
| RENAISSANCE TECHNOLOGIES LLC | 0.37% | 430,737 | 0% | $327,532 | |
| STATE STREET CORP | 0.32% | 373,142 | 0% | 0% | $283,737 |
| BlackRock, Inc. | 0.29% | 342,113 | -39% | 0% | $260,142 |
| UNITED SERVICES AUTOMOBILE ASSOCIATION | 0.26% | 302,743 | 0% | 0.02% | $230,206 |
| UBS Group AG | 0.26% | 297,270 | +31% | 0% | $225,926 |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 0.24% | 282,340 | +6.5% | 0% | $214,691 |
| GSA CAPITAL PARTNERS LLP | 0.21% | 249,716 | +157% | 0.01% | $190,000 |
| NORTHERN TRUST CORP | 0.15% | 170,471 | 0% | 0% | $129,626 |
| CWA Asset Management Group, LLC | 0.13% | 150,000 | 0% | 0% | $114,060 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.1% | 114,500 | 0% | 0% | $87,066 |
| KING LUTHER CAPITAL MANAGEMENT CORP | 0.05% | 58,000 | 0% | 0% | $44,103 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
20
Latest
Q2 2026
Rows shown
1-20 of 20
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 45,546,868 | $34,631,523 | +$5,075,458 | $0.76 | 66 |
| 2026 Q1 | 42,744,667 | $31,411,019 | -$1,642,213 | $0.73 | 73 |
| 2025 Q4 | 44,799,019 | $60,478,537 | +$47,505,485 | $1.35 | 61 |
| 2025 Q3 | 4,033,213 | $2,015,817 | -$1,258,453 | $0.50 | 36 |
| 2025 Q2 | 6,458,632 | $3,319,783 | +$1,060,111 | $0.51 | 38 |
| 2025 Q1 | 3,609,389 | $4,577,211 | -$332,797 | $1.26 | 38 |
| 2024 Q4 | 3,819,967 | $5,233,595 | -$4,950,047 | $1.37 | 42 |
| 2024 Q3 | 5,911,071 | $12,767,865 | +$5,999,502 | $2.16 | 31 |
| 2024 Q2 | 3,108,475 | $11,809,884 | -$1,252,441 | $3.80 | 33 |
| 2024 Q1 | 3,453,784 | $10,741,251 | +$509,498 | $3.11 | 35 |
| 2023 Q4 | 3,290,303 | $10,923,496 | -$819,783 | $3.32 | 33 |
| 2023 Q3 | 3,207,291 | $6,961,738 | -$151,646 | $2.18 | 32 |
| 2023 Q2 | 3,227,286 | $13,256,941 | +$994,179 | $4.12 | 34 |
| 2023 Q1 | 2,999,366 | $15,475,095 | +$204,634 | $5.16 | 35 |
| 2022 Q4 | 2,885,407 | $17,024,416 | -$1,472,942 | $5.90 | 32 |
| 2022 Q3 | 3,174,344 | $30,405,447 | +$3,581,808 | $9.58 | 30 |
| 2022 Q2 | 2,824,819 | $29,094,000 | +$2,769,956 | $10.33 | 27 |
| 2022 Q1 | 2,556,816 | $34,515,000 | +$17,568,047 | $13.50 | 23 |
| 2021 Q4 | 1,240,919 | $20,288,000 | +$544,189 | $16.35 | 21 |
| 2021 Q3 | 1,097,698 | $19,562,000 | +$19,562,000 | $17.82 | 14 |